These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
658 related items for PubMed ID: 11785853
1. Barriers to the effective management of respiratory tract infections in the community. Saginur R. Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853 [Abstract] [Full Text] [Related]
2. Antimicrobial treatment of lower respiratory tract infections in the hospital setting. Grossman RF, Rotschafer JC, Tan JS. Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675 [Abstract] [Full Text] [Related]
3. Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. J Antimicrob Chemother; 2004 Jan; 53 Suppl 1():i3-20. PubMed ID: 14726431 [Abstract] [Full Text] [Related]
4. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors. Lode H. Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852 [Abstract] [Full Text] [Related]
5. Clinical management of respiratory tract infections in the community: experience with telithromycin. Quintiliani R. Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852 [Abstract] [Full Text] [Related]
6. Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistance. Rapp RP. Postgrad Med; 2002 Sep; 112(3 Suppl):12-7. PubMed ID: 19667590 [Abstract] [Full Text] [Related]
8. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance. Doern GV. Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358 [Abstract] [Full Text] [Related]
9. Managing acute lower respiratory tract infections in an era of antibacterial resistance. Volturo GA, Low DE, Aghababian R. Am J Emerg Med; 2006 May; 24(3):329-42. PubMed ID: 16635707 [Abstract] [Full Text] [Related]
11. Primary care challenges in the management of respiratory tract infections. JAAPA; 2006 Sep; Suppl():4-14; quiz 15-6. PubMed ID: 17001773 [Abstract] [Full Text] [Related]
12. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L. Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [Abstract] [Full Text] [Related]
15. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community]. Bertrán MJ, Trilla A, Codina C, Carné X, Ribas J, Asenjo MA. Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168 [Abstract] [Full Text] [Related]